These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15313910)

  • 1. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells.
    Draffin JE; McFarlane S; Hill A; Johnston PG; Waugh DJ
    Cancer Res; 2004 Aug; 64(16):5702-11. PubMed ID: 15313910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method to measure cellular adhesion utilizing a polymer micro-cantilever.
    Gaitas A; Malhotra R; Pienta K
    Appl Phys Lett; 2013 Sep; 103(12):123702. PubMed ID: 24170959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
    Lokeshwar BL; Lokeshwar VB; Block NL
    Anticancer Res; 1995; 15(4):1191-8. PubMed ID: 7544562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
    Fillmore C; Kuperwasser C
    Breast Cancer Res; 2007; 9(3):303. PubMed ID: 17540049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
    Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.
    Josefsson A; Adamo H; Hammarsten P; Granfors T; Stattin P; Egevad L; Laurent AE; Wikström P; Bergh A
    Am J Pathol; 2011 Oct; 179(4):1961-8. PubMed ID: 21854754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation.
    Verkaik NS; Trapman J; Romijn JC; Van der Kwast TH; Van Steenbrugge GJ
    Int J Cancer; 1999 Jan; 80(3):439-43. PubMed ID: 9935187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer.
    Shang Z; Cai Q; Zhang M; Zhu S; Ma Y; Sun L; Jiang N; Tian J; Niu X; Chen J; Sun Y; Niu Y
    Oncotarget; 2015 Jan; 6(2):1202-16. PubMed ID: 25483103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer.
    Ortega Duran M; Shaheed SU; Sutton CW; Shnyder SD
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol promotes M2 polarization of tumor-associated macrophages in 4T1 mouse mammary gland cancer via the induction of proinflammatory cytokines.
    Stachowicz-Suhs M; Łabędź N; Anisiewicz A; Banach J; Kłopotowska D; Milczarek M; Piotrowska A; Dzięgiel P; Maciejczyk A; Matkowski R; Wietrzyk J
    Sci Rep; 2024 Feb; 14(1):3778. PubMed ID: 38355711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment.
    Zhang Y; Peng Q; Zheng J; Yang Y; Zhang X; Ma A; Qin Y; Qin Z; Zheng X
    Genes Dis; 2023 Sep; 10(5):2029-2037. PubMed ID: 37492749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?
    Zer NS; Ben-Ghedalia-Peled N; Gheber LA; Vago R
    Clin Exp Metastasis; 2023 Apr; 40(2):125-135. PubMed ID: 37038009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan-Induced CD44-iASPP Interaction Affects Fibroblast Migration and Survival.
    Lin CY; Basu K; Ruusala A; Kozlova I; Li YS; Skandalis SS; Heldin CH; Heldin P
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics.
    Subhan MA
    RSC Adv; 2022 Nov; 12(51):32956-32978. PubMed ID: 36425155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored hyaluronic acid-based nanogels as theranostic boron delivery systems for boron neutron cancer therapy.
    Coninx S; Kalot G; Godard A; Bodio E; Goze C; Sancey L; Auzély-Velty R
    Int J Pharm X; 2022 Dec; 4():100134. PubMed ID: 36304136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer metastasis chemoprevention prevents circulating tumour cells from germination.
    Xie X; Li Y; Lian S; Lu Y; Jia L
    Signal Transduct Target Ther; 2022 Oct; 7(1):341. PubMed ID: 36184654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Significance of MicroRNAs in the Molecular Pathology of Brain Metastases.
    Siegl F; Vecera M; Roskova I; Smrcka M; Jancalek R; Kazda T; Slaby O; Sana J
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.
    Fukuoka M; Ichikawa Y; Osako T; Fujita T; Baba S; Takeuchi K; Tsunoda N; Ebata T; Ueno T; Ohno S; Saitoh N
    Cancer Sci; 2022 Jul; 113(7):2336-2351. PubMed ID: 35415910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Model System to Study Expression Profile of RAC2 Gene in Breast Cancer MDA-MB-231 Cell Line.
    Sivakumar Harish T; Ramesh Babu P; Shrestha A; Balasubramanian B; Chinnathambi A; Ali Alharbi S
    Evid Based Complement Alternat Med; 2022; 2022():2077850. PubMed ID: 35368753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell E-selectin ligands determine partialefficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo.
    Lange T; Valentiner U; Wicklein D; Maar H; Labitzky V; Ahlers AK; Starzonek S; Genduso S; Staffeldt L; Pahlow C; Dück AM; Stürken C; Baranowsky A; Bauer AT; Bulk E; Schwab A; Riecken K; Börnchen C; Kiefmann R; Abraham V; DeLisser HM; Gemoll T; Habermann JK; Block A; Pantel K; Schumacher U
    Mol Ther; 2022 Apr; 30(4):1536-1552. PubMed ID: 35031433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.